Dabur India Ltd.
DABUR · NSE · Consumer Defensive
With a 20% margin of safety, our buy-below price is ₹323.87.
Piotroski F-score 5/9 — quality of earnings & balance sheet.
Investability checklist
- ✓ROE above 15%16.2%
- ✓Low debt (D/E < 0.5)0.11x
- ✓Positive free cash flow
- ✕Revenue growth > 10%7%
- ✓Earnings growing15%
- ✓Net margin ≥ 10%14.4%
- ✓Current ratio > 1.51.70
- ✕Below our fair value
- ✕Margin of safety ≥ 20%
- ✕Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 9.84
- ✕Piotroski ≥ 75/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
- •Financially solid — Altman Z 9.84.
Weaknesses
- •Price below its 200-day moving average (downtrend).
Opportunities
- •Earnings growing (15% YoY).
- •Trading in our value buy zone versus sector peers.
About Dabur India Ltd.
Dabur India Limited operates as a fast moving consumer goods company worldwide. It operates through Consumer Care Business, Foods Business, Retail Business, and Other segments. The company provides health supplements under the Dabur Chyawanprash, Dabur Honey, and Dabur Glucose brand name; digestive products under the Hajmola and Pudin Hara; cough and cold products under the Honitus brands name; rejuvenators under the Shilajit brand name; health juices; nutraceuticals under th
More in Fast Moving Consumer Goods
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.